Thompson Tamar
Insider CIK 1839248 · CPRX Director · RNA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 5,468 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 1,894 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 1,414 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 18,115 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 23,248 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 29,524 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 40,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer | 2026-07-15 | 2026-07-17 | 3,773 | $31.50 | $118.8K | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 13,489 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 10,034 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 22,000 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 22,000 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer | 2026-02-27 | 2026-02-27 | 6,692 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-12-08 | 2025-12-10 | 1,413 | — | $0 | 119,663 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-12-08 | 2025-12-10 | 1,413 | — | $0 | 3,773 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-11-21 | 2025-11-24 | 947 | — | $0 | 121,076 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-11-21 | 2025-11-24 | 947 | — | $0 | 2,360 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2025-11-20 | 2025-11-24 | 5,468 | — | $0 | 122,023 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2025-11-20 | 2025-11-24 | 18,115 | — | $0 | 116,555 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 10,034 | — | $0 | 10,034 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2025-06-10 | 2025-06-12 | 6,692 | — | $0 | 6,692 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-12-09 | 2024-12-11 | 1,413 | — | $0 | 98,440 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-12-09 | 2024-12-11 | 1,413 | — | $0 | 1,413 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-11-21 | 2024-11-25 | 2,841 | — | $0 | 99,853 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-11-21 | 2024-11-25 | 23,248 | — | $0 | 97,012 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2024-10-07 | 2024-10-09 | 30,000 | — | $0 | 0 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2024-10-07 | 2024-10-09 | 30,000 | $27.63 | $828.9K | 30,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2024-10-07 | 2024-10-09 | 30,000 | $44.98 | $1.35M | 0 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2024-06-13 | 2024-06-14 | 13,489 | — | $0 | 13,490 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2023-12-08 | 2023-12-12 | 4,240 | — | $0 | 73,764 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2023-12-08 | 2023-12-12 | 29,524 | — | $0 | 69,524 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2023-06-15 | 2023-06-20 | 22,000 | — | $0 | 22,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 22,000 | — | $0 | 22,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2021-01-11 | 2021-01-11 | 30,000 | — | $0 | 30,000 | SEC↗ |